Quality programmes consume more resources than any treatment and have potentially greater consequences for patient safety and other clinical outcomes. So why do we know so little about whether they are effective?
No takes yet. Share an insight, caveat, or question.
John Øvretveit (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: